|
 |
| |
|
Áö¿ÀÆ®¸³Á¤20mg(¾ÆÆÄƼ´ÕÀ̸»·¹»ê¿°) Giotrif Tab. 20mg
|
Àü¹®ÀǾàǰ | ±Þ¿© | ½Å¾à
|
|
|
¼öÀÔÀǾàǰ
|
| |
 |
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
|
| Èò»ö ³»Áö ¹ÌȲ»öÀÌ°í ¾ç¸éÀÌ º¼·ÏÇÑ ¿øÇüÀÇ Çʸ§ÄÚÆÃÁ¤ |
|
|
|
|
|
Á¦Á¶È¸»ç |
Boehringer Ingelheim
|
ÆÇ¸Åȸ»ç |
Çѱ¹º£¸µ°ÅÀΰÖÇÏÀÓ(ÁÖ)
|
Çã°¡Á¤º¸ |
Á¤»ó
(2014.01.29)
|
BIT ¾àÈ¿ºÐ·ù |
´Ü¹éÁú ÀλêÈÈ¿¼Ò ¾ïÁ¦Á¦(Protein kinase inhibitors)
|
º¹ÁöºÎºÐ·ù |
421[Ç׾ǼºÁ¾¾çÁ¦ ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
653501430 \31,355 ¿ø/1Á¤(2024.07.01)(ÇöÀç¾à°¡)\31,364 ¿ø/1Á¤(2022.01.01) (º¯°æÀü¾à°¡)
|
|
|
ATCÄÚµå |
afatinib / L01EB03 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]

|
÷°¡Á¦ |
¸¶Å©·Î°ñ400,
¹Ì°áÁ¤¼¿·ê·Î¿À½º,
»êÈÆ¼Åº,
½ºÅ׾Ƹ£»ê¸¶±×³×½·,
À¯´ç¼öȹ°,
ÄÝ·ÎÀ̵强ÀÌ»êȱԼÒ,
Å©·Î½ºÆ÷ºñµ·,
ÅÅÅ©,
Æú¸®¼Ò¸£º£ÀÌÆ® 80,
È÷ÇÁ·Î¸á·Î¿À½º
|
|
|
|
|
 |
|
|
|
|
|
| Ç× ¸ñ |
³» ¿ë |
|
|
| |
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2024-03-19 |
|
|
|
|
| |
|
|
|